Announcements Trials
Browse Landscape

Phase

Phase 2 24Phase 1/2 16Phase 1 6Phase 3 5Phase 2/3 2Phase NA 1Phase EARLY_PHASE1 1

Status

Unknown 12Completed 12Recruiting 8Terminated 7Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Radiosurgery 20Magnetic Resonance Spectroscopy 20Exercise 15Biopsy 11Surveys and Questionnaires 9Standard of Care 9Cyclophosphamide 9Educational Status 8Practice Guidelines as Topic 7Doxorubicin 7Cisplatin 7Therapeutics 6Radiotherapy 6Methods 6Fluorodeoxyglucose F18 6Early Intervention, Educational 6Blood Specimen Collection 6Radiotherapy, Intensity-Modulated 5Electroporation 5Cryosurgery 5Colonoscopy 5X-Rays 4Water 4Vincristine 4Polymerase Chain Reaction 4Palliative Care 4Irinotecan 4Drug Therapy 4Diet Therapy 4Cryotherapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Withdrawn × Capecitabine × Clear all
NCT00524069 2013-02-01

Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

Roswell Park Cancer Institute

Phase NA Withdrawn
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡